Standpoint Research Upgrades Hi Tech Pharmacal (HITK) to Buy

March 14, 2013 10:51 AM EDT
Get Alerts HITK Hot Sheet
Price: $43.49 --0%

Rating Summary:
    1 Buy, 3 Hold, 0 Sell

Rating Trend: = Flat

Today's Overall Ratings:
    Up: 35 | Down: 31 | New: 10
Trade HITK Now!
Join SI Premium – FREE
Standpoint Research upgraded Hi Tech Pharmacal (NASDAQ: HITK) from Hold to Buy with a price target of $42.00.

For an analyst ratings summary and ratings history on Hi Tech Pharmacal click here. For more ratings news on Hi Tech Pharmacal click here.

Shares of Hi Tech Pharmacal closed at $34.10 yesterday.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities

Standpoint Research

Add Your Comment